Diabetes Mellitus - PowerPoint PPT Presentation

1 / 35
About This Presentation
Title:

Diabetes Mellitus

Description:

Title: Diabetes Mellitus Author: hho Last modified by: Jennifer Shieck Created Date: 2/18/2004 7:49:49 PM Document presentation format: On-screen Show – PowerPoint PPT presentation

Number of Views:221
Avg rating:3.0/5.0
Slides: 36
Provided by: hho76
Learn more at: http://rcrmc-fmr.org
Category:

less

Transcript and Presenter's Notes

Title: Diabetes Mellitus


1
Diabetes Mellitus
2
What is diabetes mellitus?
  • Metabolic derangement with hyperglycemia

3
How DM is diagnosed?
  • Fasting plasma glucose ? 126 mg/dL on two
    occasions
  • Random plasma glucose ? 200 mg/dL with symptoms
  • Two hours glucose tolerance test with plasma
    glucose ? 200 mg/dL at 2 hour

4
Glucose intolerance?
  • Fasting plasma glucose gt110 mg/dL and lt126 mg/dL
    on two occasions
  • Two hours glucose tolerance test with plasma
    glucose gt140 mg/dL and lt200mg/dL at 2 hour

5
Other causes of hyperglycemia?
  • Endocrine diseases
  • Cushing's syndrome
  • Acromegaly
  • Pheochromocytoma
  • Glucagonoma
  • Hyperthyroidism
  • Drug-induced
  • Glucocorticoids
  • Thiazides
  • Nicotinic acid

6
Type of diabetes?
  • Type 1
  • Insulin deficiency
  • Early age onset
  • Acute onset
  • Ketosis
  • Thin
  • Type 2
  • Insulin resistance
  • Late onset
  • Gradual, slow onset
  • Usually non-ketotic
  • Obese

7
Diabetes Mellitus type 2
8
Epidemiology
  • Distribution 75-90 of diabetes mellitus
  • Incidence
  • 3/1000 new cases in Caucasian populations per
    year (probably an underestimate)
  • May be 2-4 times higher according to some
    reporting agencies
  • Prevalence
  • Affects 50-70/1000 people in the US
  • A further 27/1000 have undiagnosed diabetes on
    the basis of fasting glucose

9
Predisposing factors?
  • Age
  • Prevalence increases with age
  • Diagnosed at over 40, although the group with the
    largest and fastest increase in incidence is
    under age 25
  • Prior history of gestational diabetes
  • Obesity

10
Predisposing factors
  • Race
  • Prevalence is increased in
  • African-Americans
  • Hispanic-Americans
  • Native Americans
  • Asian-Americans
  • Pacific Islanders
  • Pima Indians
  • Socioeconomic status l
  • Lower socioeconomic groups

11
Predisposing factors
  • Genetics
  • Positive family history in 30 of cases
  • Concordance rates of approx. 90 in identical
    twins
  • One first-degree relative doubles the relative
    risk and two first-degree relatives increases the
    risk 4-fold
  • Not associated with specific HLA genes (unlike
    type 1 diabetes)
  • Polymorphisms have been identified within
    specific ethnic populations Polymorphisms have
    been identified within specific ethnic
    populations

12
Symptoms?
  • 40 are asymptomatic at diagnosis
  • Lethargy
  • Malaise
  • Blurred vision
  • Polyuria
  • Polydipsia
  • Frequent infections, e.g. candidiasis, balanitis,
    intertrigo, boils, cellulitis, urinary tract
    infections, vaginal yeast infections poor wound
    healing

13
Symptoms
  • 50 already develop complicationss
  • Eye - visual deterioration, blurred vision
  • Neuropathy - numbness/paresthesias
  • Angina
  • Intermittent claudication
  • Impotence

14
Physical findings?
  • Obesity (BMI gt26), especially centripetal obesity
  • Eye signs - cataracts, microaneurysms,
    hemorrhages, hard exudates, soft exudates, new
    vessel formation, vitreous hemorrhage, macular
    degeneration

15
Physical findings
  • Cardiac congestive heart failure from prior MI
  • Foot - decreased peripheral pulses, decreased
    protective sensation, absent ankle-jerk reflex,
    ulcers
  • Polyneuropathy, mononeuropathy (less common than
    polyneuropathy)
  • Associated hypertension

16
Associated metabolic disorders?
  • Blood pressure 130/85
  • Glucose intolerance with FBS 110 mg/dL
  • Triglyceride gt150 mg/dL or HDL lt40 mg/dL in males
    and lt50 mg/dL in females
  • Abdominal obesity with waist circumference gt102
    cm for males and gt89 cm for female

17
Tests?
  • Fasting plasma glucose
  • Hemoglobin A1c
  • Elevated in uncontrolled diabetes, lead toxicity,
    iron-deficiency anemia, hypertriglyceridemia
  • Decreased in hemolytic anemias, chronic renal
    failure
  • Fasting lipid panel
  • Bun/Cr

18
Tests
  • Magnesium
  • Homocysteine marker for cardiovascular risk
  • Urine microalbumin and urinalysis
  • EKG

19
Treatments
  • Control the hyperglycemia
  • Management the complications

20
Treatment options
  • Diet
  • Exercise
  • Medications
  • Stimulating insulin secretion
  • Block hepatic gluconeogenesis
  • Increase insulin sensitivity
  • Decrease GI absorption of glucose
  • Insulin

21
Insulin secretagogues
  • Sulonylureas
  • First-generation chlorpropamide, tolazamide,
    tolbutamide
  • Second-generation
  • glyburide and glipizide
  • Glimepiride enhance peripheral insulin
    sensitivity
  • Contraindicated in severe hepatic or renal
    disease
  • Meglitinides
  • Repaglinide, nateglinide
  • Attenuated without exogenous glucose
  • Contraindication in hepatic impairment

22
Metformin
  • Block hepatic gluconeogenesis
  • Increase muscle sensitivity to insulin
  • Contraindications
  • Cr ? 1.5 in male and 1.4 in female
  • CHF
  • Contrast dye

23
Thiazolidinediones
  • Rosiglitazone and pioglitazone
  • Increase peripheral sensitivity to insulin
  • Monitor liver function tests to due to increased
    risk of hepatitis

24
Arbacose
  • Diarrhea
  • Follow LFT periodically
  • Contraindications
  • Hepatic or renal impairment
  • IBD
  • GI obstruction

25
Insulin
  • Long acting for basal rate
  • Short acting for meal
  • May combine with oral medications

26
Hemoglobin A1c goal?
  • lt 7

27
Aspirin
  • Secondary prevention
  • Primary prevention
  • gt age 40 with cardiovascular risk factor(s)
  • Not less age 21 because of increased risk of
    Reyes syndrome

28
Hypertension goal?
  • Keep blood pressure lt 130/80 mmHg

29
Cholesterol goal?
  • LDL lt 100 mg/dL

30
Periodic exams?
  • Annual dilated eye exam
  • Annual monofilament test
  • Annual urine microalbumin
  • Annual serum creatinine
  • Annual fasting lipid panel
  • Hemoglobin A1c every 3 months

31
Screening?
  • gt age 45 and every 3 years
  • Obesity with BMI gt27kg/m2
  • First relative with diabetes
  • High-risk ethnic group
  • GDM or macrosomia baby
  • HDL ?35 mg/dL and TG ?250 mg/dL
  • Disorder associated with insulin resistance such
    as PCO

32
Hypoglycemia symptoms
  • Adrenergic symptoms tachycardia, palpitations,
    tremor, anxiety, and sweating
  • Neuroglycopenic infaintness, feeling of hunger,
    headache, abnormal behavior, altered
    consciousness, and eventually coma

33
Hypoglycemia treatment
  • Intravenous or intramuscular glucagon 1mg
  • 20-50mL of 50 intravenous dextrose, followed by
    an infusion of 10-20 dextrose

34
Neuropathy
  • Peripheral neuropathy Elavil or Neurontin
  • Erectile dysfunction Viagra

35
Diabetic foot ulcer
  • Control blood glucose
  • Callus shaving
  • Dressing changes
  • Osteomyelitis leading to amputation
Write a Comment
User Comments (0)
About PowerShow.com